REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hepatunn Europe Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Merchant Wholesalers, Durable Goods | Real Estate | Rental and Leasing Services | Legal Services | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Ambulatory Health Care Services | Other Personal Care Services
Full name: Hepatunn Europe Sp. z o.o. Profile Updated: September 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Hepatunn Europe Sp. z o.o. is based in Poland. The head office is in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on October 26, 2020. A negative growth of 63.18% was recorded in its total assets.

Headquarters
Ul. Dluga 29
Warsaw; Mazowieckie; Postal Code: 00-238

Contact Details: Purchase the Hepatunn Europe Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hepatunn Europe Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Hepatunn Europe Sp. z o.o. report to view the information.
Incorporation Date:
October 26, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hepatunn Europe Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-102.91%▼
Net Profit (Loss) for the Period
-102.91%▼
Total assets
-63.18%▼
Total equity
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo